Pregled bibliografske jedinice broj: 1036037
POSTINJECTION DELIRIUM/SEDATION SYNDROME (PDSS) FOLLOWING OLANZAPINE LONG-ACTING INJECTION: A CASE REPORT
POSTINJECTION DELIRIUM/SEDATION SYNDROME (PDSS) FOLLOWING OLANZAPINE LONG-ACTING INJECTION: A CASE REPORT // Psychiatria Danubina, 29 (2017), 1; 90-91 (međunarodna recenzija, članak, stručni)
CROSBI ID: 1036037 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
POSTINJECTION DELIRIUM/SEDATION SYNDROME (PDSS) FOLLOWING OLANZAPINE LONG-ACTING INJECTION: A CASE REPORT
Autori
Uglešić, Lovro ; Glavina, Trpimir ; Lasić, Davor ; Kaliterna, Mariano
Izvornik
Psychiatria Danubina (0353-5053) 29
(2017), 1;
90-91
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, stručni
Ključne riječi
POSTINJECTION DELIRIUM/SEDATION SYNDROME, OLANZAPINE
Sažetak
Postinjection delirium/sedation syndrome (PDSS) following olanzapine long-acting injection (LAI) is a serious adverse event, which includes symptoms of sedation (ranging from mild in severity to excessive, i.e. coma) and/or delirium (including confusion, disorientation, agitation, anxiety and other cognitive impairment). Since introduction of olanzapine LAI into our department (February of 2012), we administered approximately 4000 injections and had only one case of PDSS (0.025% of injections).
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
KBC Split,
Medicinski fakultet, Split
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- Social Science Citation Index (SSCI)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE